InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by Hirsch Andrew, 董事长兼首席执行官. Insider active across 1 company, notably C4 Therapeutics, Inc.. In total, 12 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €78k. Activity tracked since 12 April 2022. The latest transaction was disclosed on 13 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Hirsch Andrew is President & CEO and a declarant for C4 Therapeutics, Inc. (XNAS). He has filed 12 forms in total. Across the 12 sampled recent filings, purchases amount to EUR 77590, sales to EUR 0, and the most common transaction nature is option exercise, over the period from 2022-04-12 to 2026-02-18.